Market revenue in 2023 | USD 602.7 million |
Market revenue in 2030 | USD 812.0 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Cystitis |
Fastest growing segment | Pyelonephritis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Urethritis, Cystitis, Pyelonephritis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to urinary tract infection testing market will help companies and investors design strategic landscapes.
Cystitis was the largest segment with a revenue share of 41.26% in 2023. Horizon Databook has segmented the Global urinary tract infection testing market based on urethritis, cystitis, pyelonephritis covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global urinary tract infection testing market , including forecasts for subscribers. This global databook contains high-level insights into Global urinary tract infection testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account